Novo Nordisk is slashing the price of its blockbuster diabetes drug Ozempic for U.S. patients who self-pay or are uninsured.

The drug company announced Monday that patients with Type 2 diabetes can get a month's supply of the medication for $499 — less than half of the list price of nearly $1,350 for those without health insurance. Patients with a prescription for Ozempic can get the diabetes treatment on Ozempic.com or through the NovoCare Pharmacy, the drugmaker's direct-to-consumer online pharmacy which offers home delivery of prescriptions drugs for cash-paying customers.

Patients will also be able to get Ozempic for $499 through the drug discount platform GoodRx, which also offers Wegovy for $499 per month at more than 70,000 participating pharmacies nationwide.

"Improving acc

See Full Page